| 英文名称 |
中文名称 |
CAS |
|
Metronidazole Impurity20
|
甲硝唑杂质20 |
16230-87-8 |
|
Duloxetine EP Impurity G
|
度洛西汀EP杂质G |
321-38-0 |
|
L-Valine methyl ester hydrochloride
|
L-缬氨酸甲酯盐酸盐 |
6306-52-1 |
|
Pomalidomide Impurity 15
|
泊马度胺杂质15 |
1957236-21-3 |
|
Iopromide EP Impurity G(Mixture of Diastereomers)
|
碘普罗胺EP杂质G（非对映异构体混合物） |
154361-53-2 |
|
Valsartan N2-Trityl Impurity
|
缬沙坦 N2-三苯甲基杂质 |
|
|
Iopromide Impurity 6
|
碘普罗胺杂质6 |
73334-07-3 |
|
Duloxetine EP Impurity C(HBr)
|
度洛西汀杂质C(HBr) |
949096-01-9 |
|
Pomalidomide Impurity 17
|
泊马度胺杂质17 |
835616-60-9 |
|
(S)-Pomalidomide
|
(s)-泊马度胺 |
202271-89-4 |
|
Lurasidone Metabolite02
|
鲁拉西酮代谢物02 |
|
|
lurasidone impurity37
|
鲁拉西酮杂质37 |
1260025-93-1 |
|
lurasidone impurity11
|
鲁拉西酮杂质11 |
14100-97-1 |
|
Valsartan Impurity 4
|
缬沙坦杂质 4 |
1266616-11-8 |
|
Pomalidomide Impurity 1
|
泊马度胺杂质1 |
92792-46-6 |
|
Valsartan Benzyl Ester N1-Trityl Analog
|
缬沙坦苄酯 N1-三苯甲基类似物 |
|
|
lurasidone impurity26
|
鲁拉西酮杂质26 |
186204-35-3 |
|
5-Hydroxy-6-methoxy duloxetine sulfate
|
5-羟基-6-甲氧基硫酸度洛西汀 |
732983-57-2 |
|
Metronidazole EP Impurity F
|
甲硝唑EP杂质F |
16156-94-8 |
|
Metronidazole Impurity15
|
甲硝唑杂质15 |
542-05-2 |
|
Metronidazole Impurity 3
|
甲硝唑杂质3 |
87009-72-1 |
|
lurasidone impurity9
|
鲁拉西酮杂质9 |
1932552-08-3 |
|
lurasidone impurity16
|
鲁拉西酮杂质16 |
1318074-25-7 |
|
Valsartan Impurity 10
|
缬沙坦杂质 10 |
1314799-74-0 |
|
Metronidazole Impurity2
|
甲硝唑杂质2（苯甲酸甲硝唑） |
13182-89-3 |
|
Metronidazole Impurity8
|
甲硝唑杂质8 |
113385-77-6 |
|
Valsartan Impurity 9
|
缬沙坦杂质 9 |
137863-90-2 |
|
Valsartan Impurity 1
|
缬沙坦杂质 1 |
168072-17-1 |
|
Duloxetine Impurity 7
|
度洛西汀杂质 7 |
763079-11-4 |
|
Lurasidone Oxidation Impurities
|
鲁拉西酮氧化杂质 |
|
|
lurasidone impurity22
|
鲁拉西酮杂质22 |
139563-24-9 |
|
Pomalidomide Impurity 6
|
泊马度胺杂质6 |
1795373-54-4 |
|
Pomalidomide Impurity 18
|
泊马度胺杂质18 |
1957235-67-4 |
|
lurasidone impurity1
|
鲁拉西酮杂质1 |
223586-82-1 |
|
(S)-Duloxetine Phthalamide
|
(S)-度洛西汀邻苯二甲酰胺 |
199191-67-8 |
|
lurasidone impurity29
|
鲁拉西酮杂质29 |
66347-68-0 |
|
Duloxetine Impurity 18
|
度洛西汀杂质 18 |
116817-84-6 |
|
Duloxetine Impurity8
|
度洛西汀杂质8 |
5424-47-5 |
|
lurasidone impurity18
|
鲁拉西酮杂质18 |
1318074-24-6 |
|
Isoleucine Valsartan
|
异亮氨酸缬沙坦 |
137862-78-3 |
|
Pomalidomide Impurity 5
|
泊马度胺杂质5 |
19171-18-7 |
|
Pomalidomide Impurity 2
|
泊马度胺杂质2 |
603-11-2 |
|
Hydroxy Metronidazole
|
羟基甲硝唑 |
4812-40-2 |
|
rac-Valsartan Ethyl Ester
|
外消旋缬沙坦乙酯 |
1894176-41-0 |
|
Valsartan N1-Trityl Impurity
|
缬沙坦 N1-三苯甲基杂质 |
|
|
lurasidone impurity20
|
鲁拉西酮杂质20 |
186204-37-5 |
|
Duloxetine Impurity 12
|
度洛西汀杂质12 |
116817-26-6 |
|
Metronidazole EP Impurity D
|
甲硝唑EP杂质D |
5006-68-8 |
|
lurasidone impurity40
|
鲁拉西酮杂质40 |
139563-25-0 |
|
lurasidone impurity25
|
鲁拉西酮杂质25 |
1448443-35-3 |
|
Valsartan Ethyl Ester
|
缬沙坦乙酯 |
1111177-30-0 |
|
Lurasidone N-Oxide
|
鲁拉西酮 N-氧化物 |
|
|
Iopromide EP Impurity E(Mixture of Diastereomers)
|
碘普罗胺EP杂质E（非对映异构体混合物） |
154397-78-1 |
|
4-Hydroxy Valsartan
|
4-羟基缬沙坦(缬沙坦杂质） |
188259-69-0 |
|
Duloxetine Impurity 10
|
度洛西汀杂质10 |
1346599-09-4 |
|
Metronidazole EP Impurity E
|
甲硝唑EP杂质E |
705-19-1 |
|
Valsartan Benzyl Ester N2-Trityl Analog
|
缬沙坦苄酯 N2-三苯甲基类似物 |
2459446-33-2 |
|
lurasidone impurity6
|
鲁拉西酮杂质6 |
2819-48-9 |
|
Pomalidomide Impurity 21
|
泊马度胺杂质21 |
2093386-51-5 |
|
Pomalidomide Impurity 11
|
泊马度胺杂质11 |
1547162-41-3 |
|
lurasidone impurity32
|
鲁拉西酮杂质32 |
1318074-19-9 |
|
Iopromide EP Impurity H
|
碘普罗胺EP杂质H |
185459-57-8 |
|
Pomalidomide Impurity 16
|
泊马度胺杂质16 |
1950635-16-1 |
|
Valsartan Impurity 18
|
缬沙坦杂质18 |
164265-78-5 |
|
lurasidone impurity8
|
鲁拉西酮杂质8 |
1416975-23-9 |
|
Valsartan Impurity 11
|
缬沙坦杂质 11 |
1189547-11-2 |
|
Lurasidone Metabolite01
|
鲁拉西酮代谢物01 |
|
|
Valsartan EP Impurity B
|
缬沙坦EP杂质B（缬沙坦苄酯） |
137863-20-8 |
|
Valsartan Impurity 3 Sodium Salt
|
缬沙坦杂质3钠盐 |
920034-07-7 |
|
Pomalidomide Impurity 30
|
泊马度胺杂质30 |
1001852-14-7 |
|
Iopromide EP Impurity F(Mixture of Diastereomers)
|
碘普罗胺EP杂质F（非对映异构体混合物） |
154361-54-3 |
|
Pomalidomide Impurity 4
|
泊马度胺杂质4 |
585-21-7 |
|
Valsartan N-Oxide
|
缬沙坦 N-氧化物 |
|
|
Pomalidomide Impurity 19
|
泊马度胺杂质19 |
2093388-21-5 |
|
Pomalidomide Impurity 9
|
泊马度胺杂质9 |
1001852-15-8 |
|
Duloxetine Impurity 13
|
度洛西汀杂质 13 |
932013-45-1 |
|
Valsartan Impurity 8
|
缬沙坦杂质 8 |
137863-89-9 |
|
lurasidone impurity14
|
鲁拉西酮杂质14 |
2190680-18-1 |
|
Duloxetine Impurity 17
|
度洛西汀杂质 17 |
132335-44-5 |
|
Iopromide Impurity 2
|
碘普罗胺杂质2 |
102275-80-9 |
|
Duloxetine EP Impurity E
|
度洛西汀EP杂质 E |
1033803-59-6 |
|
lurasidone impurity30
|
鲁拉西酮杂质30 |
139505-45-6 |
|
Iopromide EP Impurity A
|
碘普胺EP杂质A |
154361-51-0 |
|
Pomalidomide Impurity 31
|
泊马度胺杂质31 |
202262-76-8 |
|
Valsartan Methyl Ester
|
缬沙坦甲酯 |
137863-17-3 |
|
Valsartan EP Impurity A
|
缬沙坦EP杂质A |
137862-87-4 |
|
lurasidone impurity27
|
鲁拉西酮杂质27 |
1318074-18-8 |
|
Lurasidone Sulfoxide
|
鲁拉西酮亚砜 |
1809325-45-8 |
|
Valsartan EP Impurity C
|
缬沙坦EP杂质C |
952652-79-8 |
|
Iopromide Impurity 11
|
碘普罗胺杂质11 |
1648627-33-1 |
